Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 581-585 , December 2009

Radiation-induced microenvironments – The molecular basis for free flap complications in the pre-irradiated field?

Received 13 February 2009 ,Revised 1 August 2009 ,Accepted 11 August 2009.

References 

  1. Kiener JL, Hoffman WY, Mathes SJ. Influence of radiotherapy on microvascular reconstruction in the head and neck region. Am J Surg. 1991;162:404–407
  2. Urken ML, Weinberg H, Buchbinder D, et al. Microvascular free flaps in head and neck reconstruction. Report of 200 cases and review of complications. Arch Otolaryngol Head Neck Surg. 1994;120:633–640
  3. Bozikov K, Arnez ZM. Factors predicting free flap complications in head and neck reconstruction. J Plast Reconstr Aesthet Surg. 2006;59:737–742
  4. Aitasalo K, Relander M, Virolainen E. The success rate of free flaps after preoperative irradiation in head and neck reconstruction. Ann Chir Gynaecol. 1997;86:311–317
  5. Schultze-Mosgau S, Grabenbauer GG, Radespiel-Troger M, et al. Vascularization in the transition area between free grafted soft tissues and pre-irradiated graft bed tissues following preoperative radiotherapy in the head and neck region. Head Neck. 2002;24:42–51
  6. Moran SL, Salgado CJ, Serletti JM. Free tissue transfer in patients with renal disease. Plast Reconstr Surg. 2004;113:2006–2011
  7. Schultze-Mosgau S, Wehrhan F, Grabenbauer G, et al. Transforming growth factor beta1 and beta2 (TGFbeta2/TGFbeta2) profile changes in previously irradiated free flap beds. Head Neck. 2002;24:33–41
  8. Schultze-Mosgau S, Lehner B, Rodel F, et al. Expression of bone morphogenic protein 2/4, transforming growth factor-beta1, and bone matrix protein expression in healing area between vascular tibia grafts and irradiated bone-experimental model of osteonecrosis. Int J Radiat Oncol Biol Phys. 2005;61:1189–1196
  9. Schultze-Mosgau S, Blaese MA, Grabenbauer G, et al. Smad-3 and Smad-7 expression following anti-transforming growth factor beta 1 (TGFbeta1)-treatment in irradiated rat tissue. Radiother Oncol. 2004;70:249–259
  10. Schultze-Mosgau S, Kopp J, Thorwarth M, et al. Plasminogen activator inhibitor-I-related regulation of procollagen I (alpha1 and alpha2) by antitransforming growth factor-beta1 treatment during radiation-impaired wound healing. Int J Radiat Oncol Biol Phys. 2006;64:280–288
  11. Schultze-Mosgau S, Wehrhan F, Rodel F, et al. Improved free vascular graft survival in an irradiated surgical site following topical application of rVEGF. Int J Radiat Biol Oncol Phys. 2003;57:803–812
  12. Schultze-Mosgau S, Wehrhan F, Rodel F, et al. Transforming growth factor-beta receptor-II up-regulation during wound healing in previously irradiated graft beds in vivo. Wound Repair Regen. 2003;11:297–305
  13. Schultze-Mosgau S, Blatz MB, Wehrhan F, et al. Principles and mechanisms of peri-implant soft tissue healing. Quintessence Int. 2005;36:759–769
  14. Brown BN, Valentin JE, Stewart-Akers AM, et al. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials. 2009;30:1482–1491
  15. Valentini V, Cassoni A, Marianetti TM, et al. Diabetes as main risk factor in head and neck reconstructive surgery with free flaps. J Craniofac Surg. 2008;19:1080–1084
  16. Ngo BT, Hayes KD, DiMiao DJ, et al. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol. 2005;6:225–237
  17. Ahmad TS, Musa G, Lee JK. A review of free flap failures in the University Hospital, Kuala Lumpur. Ann Acad Med Singapore. 1997;26:840–843
  18. Beausang ES, Ang EE, Lipa JE, et al. Microvascular free tissue transfer in elderly patients: the Toronto experience. Head Neck. 2003;25:549–553
  19. Martin M, Lefaix JL, Pinton P, et al. Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res. 1993;134:63–70
  20. Martin M, Lefaix J, Delanian S. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?. Int Radiat Biol Oncol Phys. 2000;47:277–290
  21. Govinden R, Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther. 2003;98:257–265
  22. Piek E, Ju WJ, Heyer J, et al. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem. 2001;276:19945–19953
  23. Weinstein M, Yang X, Deng C. Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev. 2000;11:49–58
  24. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286–1292
  25. Ulrich D, Lichtenegger F, Eblenkamp M, et al. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants. Plast Reconstr Surg. 2004;114:229–236
  26. Schiro JA, Chan BM, Roswit WT, et al. Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell. 1991;67:403–410
  27. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol. 1999;154:871–882
  28. Tibbs MK. Wound healing following radiation therapy: a review. Radiother Oncol. 1997;42:99–106
  29. Tokarek R, Bernstein EF, Sullivan F, et al. Effect of therapeutic radiation on wound healing. Clin Dermatol. 1994;12:57–70
  30. Mueller CK, Thorwarth MW, Schultze-Mosgau S. Angiogenic gene-modified fibroblasts for induction of localized angiogenesis. J Surg Res. 2009;

PII: S0167-8140(09)00446-0

doi: 10.1016/j.radonc.2009.08.009

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 581-585 , December 2009

Article Tools

* Image Usage & Resolution